Dentsply Sirona (XRAY) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Dentsply Sirona · Health Care · ref. ETF XLV · 60 calls · price $8.51
What the company does: DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide.
📈 Dentsply Sirona (XRAY) stock price
$8.51-31.8% over range
Oct 14, 25low $8.51 · high $14.68Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
20% recommend buying · 5 analysts
📊 JPI status :
Dentsply Sirona is part of our 2026 selection (JPI Fair + JPI Risk +), bought at the start of the year and tracked live. It no longer shows in today's ranking: its target has been reached, there is no gap left. See the 2026 selection and its performance →
🎯 XRAY price target & analyst consensus — price $8.51
The price target · all analysts combined (6 targets)
Highest target · 1 firm of 6$17+99.8%
Median target · of 6 targets$12+41.0%
Lowest target · 2 firms of 6$10+17.5%
Current price$8.51
Where these 6 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
6100%
$10 ↔ $17
⭐ What the most reliable analysts say
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
The consensus · 5 ratings (last 6 months)
Strong Buy00%
Buy120%
Hold360%
Sell120%
Strong Sell00%
Go deeper on the analysts
🎯 XRAY price target all
All 60 calls, one by one, with our verdict on each firm.
→ See all 60 targets, analyst by analyst💡 The best analysts on XRAY most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in XRAY? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Dentsply Sirona? The JPI assistant answers using our backtest data.
💰 Dentsply Sirona dividend: yield, history & growth › open the full page
2.89%annual yield
That's ~$0.32 per share per year.
📈 Dentsply Sirona fundamentals: valuation, margins & growth › open the full page
P/E —Net margin -15.0 %Revenue growth -4.1 %Not (yet) profitable
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. -24 %
2023
Rev +1%
2024
Rev −4%
2025
Rev −3%
🏛️ Dentsply Sirona insider buying: who's buying and how much › open the full page
6 insiders bought6 buys / 6 mo $617k👥 Cluster buy
🔎 Detailed analyses
🏛️ Which US Congress members hold Dentsply Sirona (XRAY)?
1 Congress member has disclosed XRAY buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Lois Frankel 1× · 45%
✅ Historical analyst reliability on XRAY
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| B of A Securities ↗ | 100% | +20.1% | 3 |
| Jefferies ↗ | 80% | +5.6% | 5 |
| Baird ↗ | 75% | +15.7% | 4 |
| Goldman Sachs ↗ | 67% | +23.9% | 3 |
| Credit Suisse | 67% | +1.0% | 6 |
| Piper Sandler ↗ | 50% | +21.4% | 2 |
| Stifel ↗ | 50% | +12.6% | 6 |
| Morgan Stanley ↗ | 38% | -11.1% | 16 |
| William Blair ↗ | 25% | -15.8% | 4 |
| Evercore ISI Group ↗ | 20% | -26.1% | 5 |
📊 What $1,000 invested in Dentsply Sirona would be worth › open the full page
In short — $1,000 invested in Dentsply Sirona 10 years ago would be worth $180 today, i.e. -16%/yr on average. Best year: 2019 (+33%), worst: 2024 (-43%). Price performance, excluding dividends.
If I'd invested $1,000 in Dentsply Sirona
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $537 | -46% |
| 3 years ago | $288 | -71% |
| 5 years ago | $198 | -80% |
Return by year (Dentsply Sirona)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -15% | $851 (-15%) |
| 2025 | -37% | $537 (-46%) |
| 2024 | -43% | $305 (-69%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Dentsply Sirona
Loading news…
📋 All analyst calls on XRAY
Filtered on — · ✕ show all
Piper Sandler ↗
Oct 9, 26
■ Neutral neutral · not a buy · 🎯$12
Price at call : $8.53 — gap to target +41%
Today : $8.51 — gap to target +41%
🎯 on XRAY : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Oct 9, 27
matures : Oct 9, 27
BMO Capital ↗
Sep 17, 26
■ Market Perform neutral · not a buy · 🎯$10
Price at call : $9.38 — gap to target +7%
Today : $8.51 — gap to target +18%
🎯 on XRAY : no call matured yet · 📊 on Health : 45.7% · +6.4% (35 calls)
in progress (365j)
matures : Sep 17, 27
matures : Sep 17, 27
▼ Underweight · 🎯$11
Price at call : $10.97 — upside +0%
Today : $8.51 — upside +29%
🎯 on XRAY : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Aug 24, 27
matures : Aug 24, 27
Piper Sandler ↗
Jul 29, 26
■ Neutral neutral · not a buy · 🎯$14
Price at call : $13.74 — gap to target +2%
Today : $8.51 — gap to target +65%
🎯 on XRAY : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Jul 29, 27
matures : Jul 29, 27
BMO Capital ↗
Jul 9, 26
■ Market Perform neutral · not a buy · 🎯$12
Price at call : $12.26 — gap to target -2%
Today : $8.51 — gap to target +41%
🎯 on XRAY : no call matured yet · 📊 on Health : 45.7% · +6.4% (35 calls)
in progress (365j)
matures : Jul 9, 27
matures : Jul 9, 27
▼ Underweight · 🎯$9
Price at call : $10 — upside -10%
Today : $8.51 — upside +6%
🎯 on XRAY : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
▲ Buy · 🎯$17
Price at call : $11 — upside +55%
Today : $8.51 — upside +100%
🎯 on XRAY : 0% (2 calls matureds) · 📊 on Health : 49.2% · +16.9% (124 calls)
in progress (365j)
matures : May 8, 27
matures : May 8, 27
■ Neutral neutral · not a buy · 🎯$14
Price at call : $11.14 — gap to target +26%
Today : $8.51 — gap to target +65%
🎯 on XRAY : no call matured yet · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
See the other 52 calls, newest to oldest
▼ Sell · 🎯$10
Price at call : $12.09 — upside -17%
Today : $8.51 — upside +18%
🎯 on XRAY : no call matured yet · 📊 on Health : 57% · +17.6% (128 calls)
in progress (365j)
matures : Apr 15, 27
matures : Apr 15, 27
■ Neutral neutral · not a buy · 🎯$16
Price at call : $14.31 — gap to target +12%
Today : $8.51 — gap to target +88%
🎯 on XRAY : no call matured yet · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : Mar 2, 27
matures : Mar 2, 27
Barrington Research ↗
Mar 2, 26
▲ Outperform · 🎯$17
Price at call : $14.31 — upside +19%
Today : $8.51 — upside +100%
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
in progress (365j)
matures : Mar 2, 27
matures : Mar 2, 27
Wells Fargo ↗
Feb 27, 26
■ Equal-Weight neutral · not a buy · 🎯$13
Price at call : $14.31 — gap to target -9%
Today : $8.51 — gap to target +53%
🎯 on XRAY : no call matured yet · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : Feb 27, 27
matures : Feb 27, 27
Evercore ISI Group ↗
Feb 27, 26
■ In-Line neutral · not a buy · 🎯$15
Price at call : $14.31 — gap to target +5%
Today : $8.51 — gap to target +76%
🎯 on XRAY : no call matured yet · 📊 on Health : 39.1% · -4.9% (46 calls)
in progress (365j)
matures : Feb 27, 27
matures : Feb 27, 27
■ Neutral neutral · not a buy · 🎯$14
Price at call : $14.68 — gap to target -5%
Today : $8.51 — gap to target +65%
🎯 on XRAY : no call matured yet · 📊 on Health : 48.1% · +0.7% (77 calls)
in progress (365j)
matures : Feb 27, 27
matures : Feb 27, 27
B of A Securities ↗
Feb 19, 26
▲ Buy · 🎯$17
Price at call : $12.52 — upside +36%
Today : $8.51 — upside +100%
🎯 on XRAY : no call matured yet · 📊 on Health : 64.2% · +20.2% (109 calls)
in progress (365j)
matures : Feb 19, 27
matures : Feb 19, 27
▲ Buy · 🎯$16
Price at call : $12.54 — upside +28%
Today : $8.51 — upside +88%
🎯 on XRAY : 0% (2 calls matureds) · 📊 on Health : 49.2% · +16.9% (124 calls)
in progress (365j)
matures : Feb 3, 27
matures : Feb 3, 27
■ Neutral neutral · not a buy · 🎯$14
Price at call : $12.05 — gap to target +16%
Today : $8.51 — gap to target +65%
🎯 on XRAY : no call matured yet · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : Jan 20, 27
matures : Jan 20, 27
Barrington Research ↗
Jan 5, 26
▲ Outperform · 🎯$14
Price at call : $12.37 — upside +13%
Today : $8.51 — upside +65%
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
in progress (365j)
matures : Jan 5, 27
matures : Jan 5, 27
Barrington Research ↗
Dec 16, 25
▲ Outperform · 🎯$14
Price at call : $11.43 — upside +22%
Today : $8.51 — upside +65%
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
in progress (365j)
matures : Dec 16, 26
matures : Dec 16, 26
■ Neutral neutral · not a buy · 🎯$12
Price at call : $11.37 — gap to target +6%
Today : $8.51 — gap to target +41%
🎯 on XRAY : no call matured yet · 📊 on Health : 48.1% · +0.7% (77 calls)
in progress (365j)
matures : Dec 16, 26
matures : Dec 16, 26
▼ Underweight · 🎯$12
Price at call : $11.65 — upside +3%
Today : $8.51 — upside +41%
🎯 on XRAY : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Dec 9, 26
matures : Dec 9, 26
Barrington Research ↗
Nov 10, 25
▲ Outperform · 🎯$14
Price at call : $11 — upside +27%
Today : $8.51 — upside +65%
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
in progress (365j)
matures : Nov 10, 26
matures : Nov 10, 26
■ Neutral neutral · not a buy · 🎯$12
Price at call : $11 — gap to target +9%
Today : $8.51 — gap to target +41%
🎯 on XRAY : no call matured yet · 📊 on Health : 49% · +7.1% (147 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
Wells Fargo ↗
Nov 7, 25
■ Equal-Weight neutral · not a buy · 🎯$12
Price at call : $11 — gap to target +9%
Today : $8.51 — gap to target +41%
🎯 on XRAY : no call matured yet · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
William Blair ↗
Nov 7, 25
■ Market Perform neutral · not a buy
🎯 on XRAY : no call matured yet · 📊 on Health : 50% · +37.8% (20 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
Barrington Research ↗
Oct 29, 25
▲ Outperform · 🎯$18
Price at call : $12.86 — upside +40%
Today : $8.51 — upside +112%
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
in progress (365j)
matures : Oct 29, 26
matures : Oct 29, 26
▲ Buy · 🎯$23
Price at call : $12.86 — upside +79%
Today : $8.51 — upside +170%
🎯 on XRAY : 0% (2 calls matureds) · 📊 on Health : 49.2% · +16.9% (124 calls)
in progress (365j)
matures : Oct 28, 26
matures : Oct 28, 26
Evercore ISI Group ↗
Oct 8, 25
■ In-Line neutral · not a buy · 🎯$13
Price at call : $12.38 — gap to target +5%
Today : $8.51 — gap to target +53%
🎯 on XRAY : no call matured yet · 📊 on Health : 39.1% · -4.9% (46 calls)
in progress (365j)
matures : Oct 8, 26
matures : Oct 8, 26
■ Hold neutral · not a buy
🎯 on XRAY : 0% (3 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
in progress (365j)
matures : Sep 26, 26
matures : Sep 26, 26
▲ Buy · 🎯$24
Price at call : $12.53 — upside +92%
Today : $8.51 — upside +182%
Expected +92% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (2 calls matureds) · 📊 on Health : 49.2% · +16.9% (124 calls)
-6.9%
stock -7% · XLV +29%
matured Aug 8, 26
Barrington Research ↗
Aug 8, 25
▲ Outperform · 🎯$18
Price at call : $12.53 — upside +44%
Today : $8.51 — upside +112%
Expected +44% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
-6.9%
stock -7% · XLV +29%
matured Aug 8, 26
Wells Fargo ↗
Aug 8, 25
■ Equal-Weight neutral · not a buy · 🎯$15
Price at call : $12.53 — gap to target +20%
Today : $8.51 — gap to target +76%
🎯 on XRAY : no call matured yet · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : Aug 8, 26
matures : Aug 8, 26
■ Hold neutral · not a buy · 🎯$17
Price at call : $12.53 — gap to target +36%
Today : $8.51 — gap to target +100%
🎯 on XRAY : no call matured yet · 📊 on Health : 48% · +12.3% (100 calls)
in progress (365j)
matures : Aug 8, 26
matures : Aug 8, 26
Barrington Research ↗
Jul 22, 25
▲ Outperform · 🎯$21
Price at call : $16.85 — upside +25%
Today : $8.51 — upside +147%
Expected +25% · Actual -25% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
-24.5%
stock -25% · XLV +18%
matured Jul 22, 26
■ Hold neutral · not a buy
🎯 on XRAY : 0% (3 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
in progress (365j)
matures : Jul 21, 26
matures : Jul 21, 26
Barrington Research ↗
May 12, 25
▲ Outperform · 🎯$21
Price at call : $16.75 — upside +25%
Today : $8.51 — upside +147%
Expected +25% · Actual -34% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
-34.3%
stock -34% · XLV +7%
matured May 12, 26
▲ Buy · 🎯$25
Price at call : $16.75 — upside +49%
Today : $8.51 — upside +194%
Expected +49% · Actual -35% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (2 calls matureds) · 📊 on Health : 49.2% · +16.9% (124 calls)
-34.9%
stock -35% · XLV +5%
matured May 10, 26
Piper Sandler ↗
Apr 30, 25
■ Neutral neutral · not a buy · 🎯$16
Price at call : $13.93 — gap to target +15%
Today : $8.51 — gap to target +88%
🎯 on XRAY : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Apr 30, 26
matures : Apr 30, 26
■ Neutral neutral · not a buy · 🎯$18
Price at call : $15.56 — gap to target +16%
Today : $8.51 — gap to target +112%
🎯 on XRAY : no call matured yet · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : Mar 13, 26
matures : Mar 13, 26
■ Hold neutral · not a buy
🎯 on XRAY : 0% (3 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
in progress (365j)
matures : Mar 13, 26
matures : Mar 13, 26
Wells Fargo ↗
Feb 28, 25
■ Equal-Weight neutral · not a buy · 🎯$19
Price at call : $15.99 — gap to target +19%
Today : $8.51 — gap to target +123%
🎯 on XRAY : no call matured yet · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : Feb 28, 26
matures : Feb 28, 26
Barrington Research ↗
Feb 28, 25
▲ Outperform · 🎯$20
Price at call : $15.99 — upside +25%
Today : $8.51 — upside +135%
Expected +25% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
-10.5%
stock -11% · XLV +6%
matured Feb 28, 26
■ Neutral neutral · not a buy · 🎯$20
Price at call : $16.55 — gap to target +21%
Today : $8.51 — gap to target +135%
🎯 on XRAY : no call matured yet · 📊 on Health : 48.1% · +0.7% (77 calls)
in progress (365j)
matures : Feb 28, 26
matures : Feb 28, 26
▲ Buy · 🎯$23
Price at call : $16.55 — upside +39%
Today : $8.51 — upside +170%
Expected +39% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (3 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
-13.5%
stock -14% · XLV +6%
matured Feb 28, 26
Wells Fargo ↗
Feb 14, 25
■ Equal-Weight neutral · not a buy · 🎯$20
Price at call : $18.32 — gap to target +9%
Today : $8.51 — gap to target +135%
🎯 on XRAY : no call matured yet · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : Feb 14, 26
matures : Feb 14, 26
▲ Buy · 🎯$25
Price at call : $18.37 — upside +36%
Today : $8.51 — upside +194%
Expected +36% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (3 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
-30.3%
stock -30% · XLV +7%
matured Feb 11, 26
▲ Buy · 🎯$25
Price at call : $20.31 — upside +23%
Today : $8.51 — upside +194%
Expected +23% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (3 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
-38.6%
stock -39% · XLV +5%
matured Jan 30, 26
■ Hold neutral · not a buy · 🎯$20
Price at call : $19.44 — gap to target +3%
Today : $8.51 — gap to target +135%
🎯 on XRAY : no call matured yet · 📊 on Health : 48.3% · +10.7% (116 calls)
in progress (365j)
matures : Jan 23, 26
matures : Jan 23, 26
Evercore ISI Group ↗
Jan 7, 25
■ In-Line neutral · not a buy · 🎯$20
Price at call : $18.61 — gap to target +7%
Today : $8.51 — gap to target +135%
🎯 on XRAY : no call matured yet · 📊 on Health : 39.1% · -4.9% (46 calls)
in progress (365j)
matures : Jan 7, 26
matures : Jan 7, 26
Morgan Stanley ↗
Dec 17, 24
▲ Overweight · 🎯$23
Price at call : $18.68 — upside +23%
Today : $8.51 — upside +170%
Expected +23% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (1 call matured) · 📊 on Health : 42% · -0.8% (200 calls)
-39.6%
stock -40% · XLV +12%
matured Dec 17, 25
Barrington Research ↗
Nov 8, 24
▲ Outperform · 🎯$24
Price at call : $17.65 — upside +36%
Today : $8.51 — upside +182%
Expected +36% · Actual -38% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
-37.7%
stock -38% · XLV -1%
matured Nov 8, 25
Leerink Partners ↗
Nov 7, 24
■ Market Perform neutral · not a buy
🎯 on XRAY : 0% (1 call matured) · 📊 on Health : 58.3% · +20.9% (12 calls)
in progress (365j)
matures : Nov 7, 25
matures : Nov 7, 25
Barrington Research ↗
Sep 20, 24
▲ Outperform · 🎯$36
Price at call : $26.17 — upside +38%
Today : $8.51 — upside +323%
Expected +38% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
-49.4%
stock -49% · XLV -12%
matured Sep 20, 25
Barrington Research ↗
Jul 8, 24
▲ Outperform · 🎯$38
Price at call : $24.2 — upside +57%
Today : $8.51 — upside +347%
Expected +57% · Actual -32% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
-31.5%
stock -32% · XLV -7%
matured Jul 8, 25
Barrington Research ↗
May 3, 24
▲ Outperform · 🎯$38
Price at call : $28.25 — upside +35%
Today : $8.51 — upside +347%
Expected +35% · Actual -51% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
-51.0%
stock -51% · XLV -2%
matured May 3, 25
Barrington Research ↗
Apr 18, 24
▲ Outperform · 🎯$41
Price at call : $30.5 — upside +34%
Today : $8.51 — upside +382%
Expected +34% · Actual -58% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
-58.0%
stock -58% · XLV -5%
matured Apr 18, 25
Barrington Research ↗
Mar 1, 24
▲ Outperform · 🎯$41
Price at call : $33.28 — upside +23%
Today : $8.51 — upside +382%
Expected +23% · Actual -52% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
-51.9%
stock -52% · XLV +2%
matured Mar 1, 25
Leerink Partners ↗
Feb 26, 24
▲ Outperform · 🎯$42
Price at call : $33.69 — upside +25%
Today : $8.51 — upside +394%
Expected +25% · Actual -44% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (1 call matured) · 📊 on Health : 58.3% · +20.9% (12 calls)
-44.1%
stock -44% · XLV +1%
matured Feb 25, 25
Barrington Research ↗
Nov 3, 23
▲ Outperform · 🎯$41
Price at call : $28.56 — upside +44%
Today : $8.51 — upside +382%
Expected +44% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
-18.3%
stock -18% · XLV +14%
matured Nov 2, 24
Barrington Research ↗
Aug 4, 23
▲ Outperform · 🎯$51
Price at call : $39.49 — upside +29%
Today : $8.51 — upside +499%
Expected +29% · Actual -38% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
-38.0%
stock -38% · XLV +10%
matured Aug 3, 24
Frequently asked questions
Should I buy Dentsply Sirona stock?
This isn't buy advice. For Dentsply Sirona, the analyst consensus is "Hold", with an average price target of $12.00 (+41% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (3 calls tracked on Dentsply Sirona). We show the numbers — you decide.
Is it too late to buy Dentsply Sirona? How high can it go?
The most bullish analyst target on Dentsply Sirona is $17.00 (+100% above today's price); the average is $12.00. That's the upside they see. Check how reliable those analysts have actually been on Dentsply Sirona on our site before trusting it.
Is Dentsply Sirona still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 14 analysts have a real record on Dentsply Sirona, the best hitting 100% over 3 calls. Current consensus: "Hold". Make your call on data, not noise.
Will Dentsply Sirona stock recover (go back up)?
It's down from its high. We answer with the numbers — the analysts' 12-month target and what happened after its past drops: will XRAY stock recover (go back up)?
Should you invest in Dentsply Sirona? The case for and against
The arguments for and against, one by one, from the numbers: why invest in XRAY (and why hesitate).
What has Dentsply Sirona's past performance been?
Historical returns and a "how much if I had invested" calculator: XRAY performance & returns.
Does Dentsply Sirona pay a dividend?
Yield, consistency and growth history of the dividend: XRAY's dividend.
What is the best month to buy XRAY?
The 12 months ranked by the stock's past returns: best & worst month to buy XRAY.
Are insiders buying XRAY stock?
Executives' and large holders' buys and sells, decoded: insider buying on XRAY.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX